Waddell & Reed Financial’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $18.3M | Sell |
40,123
-76
| -0.2% | -$34.7K | 0.04% | 369 |
|
|
2020
Q4 | $18.7M | Sell |
40,199
-80,331
| -67% | -$37.4M | 0.04% | 357 |
|
|
2020
Q3 | $53.2M | Sell |
120,530
-17,479
| -13% | -$7.72M | 0.13% | 189 |
|
|
2020
Q2 | $50M | Buy |
138,009
+36,189
| +36% | +$13.1M | 0.13% | 190 |
|
|
2020
Q1 | $28.9M | Sell |
101,820
-1,057
| -1% | -$300K | 0.09% | 234 |
|
|
2019
Q4 | $33.4M | Hold |
102,877
| – | – | 0.08% | 257 |
|
|
2019
Q3 | $30M | Sell |
102,877
-173
| -0.2% | -$50.4K | 0.08% | 268 |
|
|
2019
Q2 | $30.3M | Hold |
103,050
| – | – | 0.07% | 280 |
|
|
2019
Q1 | $28.2M | Buy |
103,050
+130
| +0.1% | +$35.6K | 0.07% | 296 |
|
|
2018
Q4 | $23M | Buy |
102,920
+1,850
| +2% | +$414K | 0.07% | 303 |
|
|
2018
Q3 | $24.7M | Sell |
101,070
-7,880
| -7% | -$1.92M | 0.05% | 308 |
|
|
2018
Q2 | $22.6M | Sell |
108,950
-24,830
| -19% | -$5.14M | 0.05% | 322 |
|
|
2018
Q1 | $27.6M | Hold |
133,780
| – | – | 0.06% | 290 |
|
|
2017
Q4 | $25.4M | Sell |
133,780
-1,370
| -1% | -$260K | 0.06% | 305 |
|
|
2017
Q3 | $25.6M | Sell |
135,150
-7,230
| -5% | -$1.37M | 0.06% | 301 |
|
|
2017
Q2 | $24.8M | Sell |
142,380
-19,260
| -12% | -$3.36M | 0.05% | 320 |
|
|
2017
Q1 | $24.8M | Sell |
161,640
-5,460
| -3% | -$839K | 0.05% | 321 |
|
|
2016
Q4 | $23.6M | Sell |
167,100
-56,850
| -25% | -$8.02M | 0.05% | 323 |
|
|
2016
Q3 | $35.6M | Buy |
+223,950
| New | +$35.6M | 0.07% | 254 |
|